South Korean Pharmaceuticals & Biotech Insider-Bought Value Plays

Dong-A Socio Holdings

Market Cap: ₩549.5b

Engages in the pharmaceutical business in South Korea.

Daewon Pharmaceutical

Market Cap: ₩171.5b

A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.

PharmaResearch

Market Cap: ₩3.3t

Operates as a biopharmaceutical company primarily in South Korea.

HansBiomed

Market Cap: ₩358.0b

Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.

BIO-FD&CLtd

Market Cap: ₩74.3b

Develops active ingredients for anti-aging cosmetics in South Korea.

Macrogen

Market Cap: ₩131.0b

Provides precision medicine and bio-engineering healthcare services in Korea and internationally.

Ilyang PharmaceuticalLtd

Market Cap: ₩153.6b

Operates as a pharmaceutical company primarily in South Korea.

Ildong Holdings

Market Cap: ₩69.1b

Develops, manufactures, and supplies pharmaceutical products in South Korea and internationally.

JW Holdings

Market Cap: ₩270.2b

Operates as a healthcare company in South Korea, the United States, Japan, China, and internationally.

Seegene

Market Cap: ₩1.3t

Manufactures and sells molecular diagnostics products worldwide.

Medy-Tox

Market Cap: ₩473.8b

Operates as a biopharmaceutical company in South Korea.

Korea Arlico PharmLtd

Market Cap: ₩38.1b

Engages in the researches and develops, produces, and sells medicines in South Korea.

GeneBioTech Ltd

Market Cap: ₩39.8b

Engages in the manufacture and sale of feed additives and functional food in South Korea.